Jpmorgan Chase & Co »

Praxis Precision Medicines I shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $378 17 22.29

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding Praxis Precision Medicines I

Point72 Asset Management
Partner Fund Management
Cormorant Asset Management
Vanguard Group
VR Adviser
Kingdon Capital Management
Bank of America Corporation
Tri Locum Partners
Ikarian Capital
Assenagon Asset Management
Blackstone Group
Jacobs Levy Equity Management
72 Investment Holdings
Citadel Advisors
Marshall Wace

View all funds holding Praxis Precision Medicines I